Unknown NA INTERVENTIONAL 2-arm NCT00359047

Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme

Sponsor: Amgen

Updated 8 times since 2017 Last updated: Nov 17, 2017 Started: Jun 30, 2003 Primary completion: Oct 31, 2007 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Osteoporosis, this trial is ongoing. The trial is conducted by Amgen and has accumulated 8 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Unknown NA

Status: Active Not Recruiting → Unknown
Sep 2025 — Feb 2026 [monthly]

Active Not Recruiting NA
Sep 2024 — Sep 2025 [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
Jan 2021 — Jul 2024 [monthly]

Active Not Recruiting NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Active Not Recruiting NA
Jul 2017 — Jun 2018 [monthly]

Active Not Recruiting NA
Jan 2017 — Jul 2017 [monthly]

Active Not Recruiting NA

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amgen
CHU de Quebec-Universite Laval
Eli Lilly and Company
Merck Frosst Canada Ltd.
Novartis
Procter and Gamble
Sanofi

Data source: CHU de Quebec-Universite Laval

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Québec, Canada